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Abstract Biofunctionalized gold and silver nanoparticles
synthesized using different plant extracts of guava and
clove in vitro anti-cancer efficacy against four different
cancer cell lines human colorectal adenocarcinoma, human
kidney, human chronic myelogenous, leukemia, bone
marrow, and human cervix have been studied and reported.
The present experimental study suggests that flavonoids
functionalized gold nanoparticles synthesized using aque-
ous clove buds extract are more potential than guava leaf
extract towards anti-cancer activities. The microscopic and
2,3-bis (2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenylamino)
carbonyl]-2H-tetrazolium hydroxide (XTT) assay infer that
the functionalized irregular shaped gold nanoparticles synthe-
sized with aqueous clove bud extract showed a satisfactory
anti-cancer effect on all the cell lines. The silver nanoparticles
synthesized using same extracts are devoid of anti-cancer
activity. The XTT assay revealed dose-dependent cytotoxicity
to cancer cell lines. The study revealed that the free radicals
generated by gold nanoparticles are responsible for anti-
cancer effect. To confirm the free-radical scavenging efficacy
of gold nanoparticle, nitric oxide assay is followed. We
observed that the gold nanoparticles swabbed the free radicals
in dose-dependent manner. With continued improvements,
these nanoparticles may prove to be potential anti-cancer
agents.
Keywords Flavonoid functionalized gold and silver
nanoparticles . Cell lines . In vitro activity . XTT assay .
Anti-cancer agent
1 Introduction
Cancer is observed as the most dangerous class of disease
categorized by uncontrolled cell growth (Chow 2010;
Suriamoorthy et al. 2010). There is a marginal increase in
cancer cases in the last few years, and most of the time, it
ends up with taking life (Dite et al. 2010; Parveen and
Sahoo 2010; Smith et al. 2010). In many types of cancer,
we are yet to find a satisfactory medicine or carrier of
medicine as in case of drug delivery to be used as a
satisfactory chemotherapeutic agent. Nanotechnology, an
interdisciplinary research field comprising chemistry, engi-
neering, biology, and medicine, has great potential for early
detection, accurate diagnosis, and tailored treatment of
cancer (Sakamoto et al. 2010). Nanoparticles are usually
smaller than several hundred nanometers in size, compara-
ble to large biological molecules such as enzymes,
receptors, of a size about 100 to 10,000 times smaller than
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human cells. These nanoparticles can offer unprecedented
interactions with biomolecules both on the surface and inside
the body cells, whichmay bring revolution in cancer diagnosis
and treatment (Seigneuric et al. 2010; Liu et al. 2010).
Nanotechnology is a burgeoning arena which takes
along with it a myriad of prospects and possibilities for
advancing disease treatment in pharmaceutical and medical
field. At nanometric scale, the physico-chemical and
biological properties of materials differ fundamentally from
their corresponding bulk counterpart because of the size-
dependent quantum effect. The noble metal nanoparticles
like gold nanoparticles (AuNP), especially surface func-
tionalized represent smart and promising candidates in the
drug delivery applications due to their unique dimensions,
tunable functionalities on the surface, and controlled drug
release (Datar and Richard 2010). Another essential aspect
while working with AuNP in bio-applications is safety and
biocompatibility (AuNP is already approved by the US
Food and Drug Administration.) Biologically synthesized
and functionalized, AuNP provide many desirable attributes
for use as carriers in drug delivery systems as the
functionalized AuNP core is essentially inert and nontoxic
1 reported in recent studies (Han et al. 2007; Kim et al.
2009). Monodispersed nanoparticles can be formed with a
core size from <30 nm and also with metal–core–organic–
shell morphology; the mono-metal layer can be tailored
with a range of biological ligands, help in effective cellular
uptake, controlled drug release, and targeted drug delivery
(Ghosha et al. 2008; Salmaso et al. 2010). These function-
alized nanodelivery systems can be used directly as
promising lead molecules in the detection of cancer cells.
In this applied research work, we have deduced and
detailed the use of synthesized bio-functional noble metal
nanoparticles application as an anti-cancer drug and
demonstrate the anti-cancer effect of these functionalized
AuNP using nitric oxide method. It gives a strong
speculation, for the influence of free electrons generated
by the surface of the functionalized AuNP has a lethal
effect on the electronegative surface membrane of the
cancer cells. The free-radical scavenging effect of AuNP is
compared with the well-known anti-oxidant butyl hydroxy
anisole (BHA), which is determined by nitric oxide method.
The end results confirm that functionalizing AuNP with the
water-soluble organic moieties can show the synergic anti-
proliferative effect in various cancer cell lines, and thus prove
to be useful in various types of anti-cancer control systems.
We have already worked for the synthesis of different
functionalized Au and Ag nanoparticles using different
plant extracts of clove and guava (Raghunandan et al. 2009;
Raghunandan et al. 2010a; Raghunandan et al. 2010b). The
characterization is elaborately discussed with respect to
size, shape stability, and functionalization using different
spectroscopic and microscopic techniques. The shape of
silver nanoparticles (AgNP) found to be roughly spherical
and in 30–60 nm and 20–30 nm range in case of guava leaf
and clove buds-mediated synthesis, respectively. The clove-
mediated AuNP yielded highly unpredictable irregular-
shaped particles in the range of 5–100 nm, whereas guava
leaf-mediated synthesis produced poly-shaped nanopar-
ticles in the narrow range of 25–30 nm. In all the cases of
noble nanoparticle synthesis, the preliminary studies using
FTIR (Fourier transformed infrared spectroscopy) confirms
that the different polyphenols of the flavonoids of the
respective plants are responsible for the biosynthesis, and
the same are capped on the surface of the nanoparticles.
Though the further studies on the exact chemical moiety
responsible for bioreduction pathway is still underway, in
this paper, we are making an effort to understand the anti-
proliferative effect of these functionalized “lead” in
different cancer cell lines. The encouraging results of
functionalized AuNP as an anti-cancer agent using different
plant extract has a promising lead for further exploitation.
2 Experimental
2.1 Biosynthesis of nanoparticles
The AuNP and AgNP were synthesized separately treating the
10−3 N HAuCl4 and 10
−3 AgNO3 solutions with guava leaf
(Psidium guajava) extract and clove bud (Syzygium aroma-
ticum) extract, respectively, as reported in our earlier research
papers (Raghunandan et al. 2009; Raghunandan et al. 2010a;
Raghunandan et al. 2010b) The flavonoid-conjugated AuNP
using guava and clove are represented as AuNP-Gua and
AuNP-Clo, respectively, and is shown in Fig. 1.
2.2 Anti-cancer activity study
Four different cells lines namely HT-29 (human colorectal
adenocarcinoma), HEK-293 (human kidney), K-562 (human
chronic myelogenous, leukemia, bone marrow), and HeLa
(human cervix) cell lines were obtained from the American
Type Culture Collection, USA. The growth media: RPMI-
1640, sufficient minimum essential medium (MEM), and the
phosphate buffer solution (PBS) tablets were obtained from
Sigma Chemical Co., St Louis, USA. Standard quality fetal
calf serum, penicillin–streptomycin, and trypsin were
obtained from Sigma labs. The XTT kit, which consists of
the 2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-5-[(phenyla-
mino)carbonyl]-2H-tetrazolium hydroxide (XTT) labeling
reagent and the solubilisation solution was procured from
Sigma labs, USA. Trypsin (0.25%+EDTA, 1 mM in PBSA),
XTT dye–50 mg/mL, sterilized Sorensen's glycine buffer
(0.1 M glycine, 0.1 M NaCl adjusted to pH 10.5 with 1 M
NaOH), DMSO, growth medium is procured from Aldrich
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labs. XTT labeling reagent and electron-coupling reagent
were thawed, respectively, in a water bath at 37°C. Each vial
was mixed thoroughly to obtain a clear solution. To perform
a cell proliferation assay (XTT) with one microplate (96
wells), 5 mL XTT labeling reagent was mixed with 0.1 mL
electron-coupling reagent.
2.3 Free-radical scavenging activity of AuNP
Aqueous solution of AuNP–clo of different concentrations
(2.5 μg, 5 μg, 10 μg/μL) were taken in different test tubes
and made up to 3 ml with 0.1 M phosphate buffer (pH 7.2).
Sodium nitroprusside (5 mM) prepared in buffered saline
(pH 7.2) and 1 mL was added to each tube. The reaction
mixture was incubated for 30 min at RT. A control without
the test compound, but with an equivalent amount of
methanol was prepared for comparison purpose. After
30 min, 1.5 mL of above solution was mixed with 1.5 mL
of Griess reagent (1% sulphanilamide, 2% phosphoric acid
and 0.1% N-1-naphthylethylenediamine dihydrochloride).
The absorbance of the samples was measured at 546 nm.
Nitric oxide radical scavenging activity was calculated
using the following formula:
%radical scavenging activity
¼ control OD aq:AuNP ODð Þ = control OD½   100
2.4 Cell culture
A 96-well micrometer plate equipment (Nunc, Denmark)
is used for this experiment. Two hundred microliters of
MEM is added in the required amount of wells; in each
cell, 50 μL of different cell lines are added. Biofunction-
alized AgNP and AuNP of different concentrations (10, 20,
30 μg/L) were added into the wells separately. The cells were
cultured in the appropriate medium supplemented with 5–
10% fetal calf serum and 1% penicillin–streptomycin, using
25 cm2 flasks in a 37°C incubator with 5% CO2. To
subculture the cells, the cells were separated, and the fresh
culture medium was used with fresh medium as follows: in
the first step, the old medium was removed, and then the
cells were rinsed briefly with PBS. After adding 1–2 μL of
trypsin, the flask was incubated at 37°C using 5% CO2 for
5 min. The upper part of the liquid is discarded, and the
detached cells, which are present in the lower part of the
flask, are taken in another flask, and after adding 20 μL of
medium to it, the culture was divided in two parts. One part
was then transferred to a new flask. The cells were grown till
they become turbid and confluent. Then, trypsin is added to
these cells to prepare a cell suspension, and the numbers of
viable cells were counted with a hemocytometer. One
hundred microliters of suspension containing 1×105 cells
was seeded in each well of a 96-well microtiter plate. The
plate was then incubated overnight at 37°C with 5% CO2.
Periodically, the medium was replaced.
2.5 Cell proliferation assay
Each cancer cell line was grown in a 96-well microtiter
plate of a final volume of 100 μL culture medium per well.
The cells were then treated with functionalized AgNP and
AuNP developed with different plant extract and bio-
Fig. 1 Microscopic image showing the anti-proliferative effect of AuNP and AgNP synthesized using aqueous extracts of guava leaf and buds of
the clove, respectively, at different concentrations. [X] indicates the absence of the activity
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excretories at a dose of 10, 20, and 30 μg/mL and maintained
them in incubator at 37°Cwith CO2 for 48 h. Fifty microliters
of the saturating solution (Roche Diagnostics, USA) was
then added into each well. The plate was kept overnight in
the incubator. Viability of the cells was counted using an
ELISA reader (ELx 800) at 550 nm. The experiment was
carried out in six replicates.
2.6 Measurement of growth-inhibitory effect
Cells were grown in 96-well plates in a final volume of
100 μL of culture medium per well. Each well contained
1×105 cells/mL and was incubated for 24 h in a 5% CO2
incubator at 37°C. As detailed above, the same procedure
was adopted for cell culture. The HeLa cell line was used as
it has the lowest IC50 (the concentration of test compound
that can inhibit 50% of the cancer cells from proliferating)
for functionalized AuNP and the same was observed using
microscope. The cells were treated with different nano-
particles at a concentration that was similar to the IC50
value. The plate was then incubated again in the 5% CO2
incubator at 37°C for 48 h. The untreated cells (control)
were also incubated for 48 h. The growth of the cells was
photographed using a phase contrast microscope (Olympus,
USA). Cells, grown in a 96-well tissue culture plate, are
incubated with the yellow XTT solution (0.3 mg/mL) for
additional 4 h.
The cells were grown till they become turbid and
confluent. Trypsin is then added to the cells to prepare a
cell suspension, and the number of viable cells was counted
with a hemocytometer. Fifty microliters of suspension
containing 1×105 cells was seeded in each well of a 96-
well microtiter plate. The plate was then incubated
overnight at 37°C with 5% CO2. Periodically, the medium
was replaced. A 96-well micrometer plates are used for this
experiment. Two hundred microliters of MEM is added in
the required number of wells; to this, 50 μL of different cell
lines are added in each well. Biofunctionalized AuNP of
different concentrations (10, 20, 30 μL) were administered
into the wells separately. The cells were cultured in the
appropriate medium, supplemented with 5–10% fetal calf
serum and 1% penicillin–streptomycin, using 25 cm2 flasks
in a 37°C incubator with 5% CO2. To subculture the cells,
the cells were separated, and the fresh culture medium was
used with fresh medium as follows: in the first step, the old
medium was removed, and then the cells were rinsed
briefly with PBS to wash the cells. After this, 1–2 μL of
trypsin was added, and the flask was incubated at 37°C and
5% CO2 for 5 min. The upper part of the liquid is
discarded, and the remaining detached cells, present in the
lower part of the flask, are taken in a separate flask; 20 μL
of medium was added, and the culture was divided in two
parts. One part of this was transferred to a new flask.
3 Result and discussion
Functionalized AuNP developed with clove buds extract
(AuNP-Clo) inhibit 50% of the proliferation of HeLa,
HEK-293, and HT-29 cancer cells at 20 μg/mL concentra-
tion. The same nanoparticles inhibited the K-562 cancer
cell line at 30 μg/mL concentration. This colorimetric assay
is based on the capacity of mitochondria succinate
dehydrogenase enzymes in living cells to reduce the yellow
water-soluble substrate XTT into an insoluble, colored
formazan product, and therefore, this conversion only
occurs in viable cells (Berridge et al. 1996). Additional
incubation period for 4 h after the addition of XTT labeling
reagent, the change in the color of the solution in different
wells is observed. A solution of orange formazan is formed,
which is quantified spectrophotometrically using an ELISA
plate reader at 490 nm (Sacconi et al. 2009). For this, a
graph of absorbance against drug (AuNP) concentration
was plotted and the inhibitory effect (IC50) was calculated.
The reduction of XTT can only occur in metabolically
active cells; the level of activity is a measure of viability of
cells. Absorbance values that are lower than the control cell
lines reveals decline in the rate of cell proliferation.
Conversely, a higher absorbance indicates an increase in
the cell proliferation. Untreated microtiter plates of cell
lines with only vehicle (0.3% v/v DMSO in water) is
considered as proliferative control.
An increase in number of living viable cells results in an
increase in the total activity of mitochondrial dehydrogenases
in the anti-malignant cells. As observed by the absorbance, the
increase is directly proportional to the orange formazan
formed quantitatively, (Leviar et al. 2003). This process is
safe, unlike available other alternatives, as no radioactive
isotopes are used. The results found are precise and can be
correlated to the number of viable cell number. The method
is also sensitive and can be used for large number of
samples. The inhibition of cell proliferation percentage by
the AuNP with different plant extracts was calculated based
on difference in inhibitory effect between treated cell lines
and their respective controls, where 100% cell proliferation
was taken from corresponding controls. Table 1 shows
growth of inhibitory effect of functionalized AuNP on
different cell lines. From the table, it is evident that clove
flavonoids-conjugated AuNP can be used effectively at a
very low concentration against different types of cancer.
3.1 Statistical analysis
All the results are expressed as mean±SD of triplicate.
The difference in inhibitory effect at different doses
between treated and corresponding controls was analyzed
for statistical significance by performing Student's t test.
P<0.05 implies significance. Nil inhibitory effect on
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cancer cell lines was observed by both extracts at dilutions
less than 10 μg/mL. Anti-proliferative activity of ethanol
extract on Vero cell line was constantly less at experi-
mented dilutions as compared to cancer cell lines.
3.2 Growth-inhibitory effect
The ability of AuNP developed from clove extract
inhibit proliferation of HEK-293, HeLa, and HT-29 cell
line at 20 μg/mL was estimated by its observed effect
on the growth of the cells. The growth of the untreated
(control) and treated HEK-293, HeLa, and HT-29 cell
line after incubation for 48 h was photographed using a
phase-contrast microscope. The observation of HEK-
293, HeLa, and HT-29 cells showed that most of the
cells were attached in the culture containing 20 μg/mL
of AuNP functionalized with clove moieties. The cells
were viable and adhered to the bottom of the well after
48 h of treatment, although a large proportion of the
cells were found in isolated condition. Cells of all
cancer cell lines are shrunken and isolated condition
after 48 h of incubation. The effect of functionalized
gold and AgNP on the proliferation of human cancer
cells was determined. The percentage of cell viability
was measured by comparing the optical density (OD) of
abovementioned cancer cells culture treated with differ-
ent functionalized AuNP against the control. AuNP
synthesized from clove, causes 50% cell death in all
human cancer cell lines tested. In this study, clove
extract-mediated AuNP has been proven to inhibit the
proliferation of three cancer cell lines out of four that
were tested at a strong IC50 value (<20 μg/mL). These
nanoparticles was not active (IC50>30 μg/mL) against
K-562. Figure 2 shows the microscopic images of wells
containing the different cancer cell lines treated with
different flavonoid-conjugated AuNP and AgNP. The
XTT assay as discussed above is done on only
flavonoid-conjugated AuNP based on the positive results
obtained by this microscopic analysis.
The freely water-soluble flavonoids present in the guava
leaf and clove buds solution that could have been adsorbed
on the surface can stimulate or suppress the immune system
due to the presence of −OH groups. Presence of such
phenolic moieties may be assumed to have synergic effect
for the anti-proliferative activities of these bio-adsorbed
metal nanoparticles (Kawaii et al. 1999; Salucci et al. 2002;
Lee and park 2010). The anti-proliferative activity is also
attributed to the irregular shape of the nanoparticles (Chen
et al. 2008). These shape-dependent properties of AuNP
have different behaviors and make them suitable for
therapeutic utilization (Greenfield 2005; Gobin et al.
2007; Kevin 2008; Sperling et al. 2008; Bertussi et al.
2005). AuNP of certain non-regular shapes can readily be
adsorbed to the surfaces of the biomolecules which show
higher surface plasmon resonance and will have a greater
contrast effect than those of photothermal dyes that are used
regularly in detection of cancer cells (Giljohann et al. 2010;
Katti et al. 2006). Here, the bio-detection sensitivity and
biocompatibility parameters become very important. The
bio-detection sensitivity of nanoparticles often is associated
with their physical and chemical properties, which in turn
depend on the shape of the particles (Rinaldo et al. 2006;
Hu et al. 2007). Nanoparticles with different dimensions
have been applied widely to detect biological molecules.
Colloidal AuNP is used to detect specific DNA sequences
and single-base mutations in a homogeneous format. AuNP
synthesized with biological base are interesting, predomi-
nantly because they exhibit the best compatibility with
biomolecules. But, bio-detection sensitivity derived from
spherical nanoparticles is not strong enough to trace the
interaction of biomolecules (Maxwell et al. 2002; Orendorff
et al. 2006). Looking into all these aspects, it is reasonable
to infer that the biosynthesis of irregular-shaped nano-
particles hopefully might reach this aim because they
display novel properties and may improve biological
detection sensitivity greatly. The shape of the noble nano-
particle will also play important role as an anti-cancer
agent. On the basis of our results, we can speculate on the
mechanisms that govern shape-dependent extracellular
effect of nanoparticles.
The microscopic image in Fig. 2 shows that the same
flavonoid-conjugated AgNP are devoid of anti-cancer effect
on all the cell lines. This study infers that the flavonoid
functionalization helps for reducing the toxicity in the host
Table 1 Growth-inhibitory effect of functionalized AuNP on different cell lines
Treatment Inhibitory effect on cell lines (IC50)
HEK-293 HeLa HT-29 HEK-293 Vero
AuNP-Clo 19.88±0.006* (62.89%) 20.05±0.002* (58.77%) 20.12±0.007* (56.78%) 28.56±0.010** (51.55%) 56.78±0.001 (32.56%)
AuNP-Gua 31.22±0.011 (48.56%) 36.11±0.001 (42.45%) 39.44±0.010 (38.54%) 45.67±0.002 (35.66%) 61.23±0.005 (28.44%)
Each value represents mean±SD. Data were analyzed by Student's t test. Number in the parenthesis denotes percent inhibition of cell proliferation
*P<0.01, **P<0.05 vs. corresponding control
Anti-cancer studies of bio-functionalized noble metal nanoparticles 61
and offers only synergic effect in case of the functionalized
AuNP. The activity might be because of the size, shape, or
other intrinsic properties of the gold nanoparticles. Many
studies prove that the gold nanoparticles of 30–50 nm range
show good anti-cancer effect. At this range, our research
shows that the irregular-shaped AuNP offers maximum
anti-cancer effect on all the cell line compared to poly-
shaped, nearly spherical, or spherical noble nanoparticles.
The most possible reason that because of their unpredict-
able shape, the moment in between the cells, and also the
non-specific adsorption to the cell surface is high compared
to particles of other shapes. Since these flavonoids are
important in the internal stabilization of gold nanoparticles,
a further detailed study is needed. This will provide a better
understanding of how this flavonoid-conjugated AuNP
disturbs and destroys the cell externally. Figure 3 shows
the pictorial representation of shape-dependent anti-cancer
effect of gold nanoparticles. The irregularly shaped nano-
particles can move easily in between the abnormally high
and irregularly spread neoplastic cells compared to poly-
shaped or roughly spherical ones; it is reasonable to infer
that these special unpredictable amoebic shaped is having
better anti-proliferative effect.
As such, the clove extract itself has reported anti-
malignant effect at higher concentration in different types
of cancer. The morphology of HeLa, HEK-293, and HT-29
cell line that were treated with AuNP-Clo at 20 μg/mL was
Fig. 3 Shape-dependent anti-proliferative activity of AuNP
Fig. 2 TEM images of AuNP
and AgNP synthesized using
aqueous extracts of guava leaf
and buds of the clove,
respectively (reproduced with
permission from A) Elsevier, B)
& C) Springer)
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studied to prove the effect of these AuNP on the cell
growth. Our observations showed that the growth of the
cells was inhibited. However, further study is needed to
understand the exact mechanism of anti-cancer activity of
these nanoparticles. AuNP-Clo proved to possess anti-
proliferative properties against all the cancer cell lines
tested. The prominent anti-proliferative effect of functional-
ized AuNP on HEK-293, HeLa, and HT-29 cancer cell lines,
as revealed by its IC50 based on XTT assay was found to be
19.88±0.006, 20.05±0.002, 20.12±0.007, and 28.56±0.010,
respectively. IC50 of AuNP-Clo was specifically less
significant on Vero cell line, i.e., 55.3±2.74. Therefore, it
can be said that AuNP-Clo is a promising anti-cancer “lead”.
However, the exact mechanism behind the anti-proliferative
effects of AuNP-Clo needs to be studied to determine
whether the effect is due to an increase in apoptosis. The
plasma membrane of the cancer cell defines the separation
between the internal constituents of a cell and the outside
environment. This semi-permeable membrane allows free
diffusion of small and non-polar molecules. However, bigger
ones like nanomaterials are incapable of crossing the plasma
membrane which requires uptake mechanisms such as
endocytosis. Most of bio-functionalized AuNP are easily
taken up by the cells through endocytotic mechanisms, but
they remain in endosome vesicles, become incapable of
reaching the cytosol system. Although endocytotic uptake is
the normal phenomenon for a variety of nanomaterials, the
efficiency predominantly depends on shape, size, the
dispersivity, and the other physico-chemical parameters. This
is important, because there may be many factors that affect
the anti-proliferative activity in the in vivo study. Further
study is underway.
AuNP-Gua has shown activity against HEK-293 but the
IC50>30 μg/mL. These are devoid of anti-proliferative
activity against other three cell lines. AuNP developed with
cow urine as a reducing agent has shown activity against
HeLa, HEK-293, and HT-29 at 30 μg/mL. Though the
Fig. 5 Graph showing free-radical scavenging activity of AuNP
Fig. 4 Probable anti-proliferative
mechanism of AuNP
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inhibitory effect is higher than that of AuNP-Clo, but
looking in to the beneficial effects of cow urine, the AuNP
synthesized with using cow urine as a reducing medium can
be a promising anti-cancer agent. Poly-shaped nanoparticles
synthesized using guava extract has shown cytotoxic effect
on HEK-293 and the IC50. Functionalized AgNP using
other different plant extract and bio-excretory have not
shown any cytotoxic effect even at 30 μg/mL. This also
proves that the adsorbed bio-moieties alone are devoid of
cytotoxic effect at that concentration.
To determine the relationship between free-radical and
anti-cancer activity, we used nitric oxide method to test
whether the antioxidant property could influence anti-cancer
activity induced by AuNP. Recently, efficacy of free-radical
generation of AuNP is studied and reported using EPR
spectroscopy and spin-trapping technique (Ionita et al.
2007). We understand that the anti-cancer effect of AuNP
is related to the generation of free radicals and subsequent
free radical-induced cancer cell surface damage (Nie et al.
2007). These free radicals attack the nearest neoplastic cell
and steals its electron. When the cell loses its electron, it
becomes a free radical itself, and begins a chain reaction.
When this cascade of reaction is initiated in the surface of the
cell wall, within a short time, the total disruption of a living
cell is seen. The progression will go on from cell-to-cell
which contributes to the electron propagation all around
entire part of the tissue. This, in turn, is responsible for
shrinkage and rupture of the cell surface and improper
nutrient and signal supply. Figure 4 shows the pictorial
diagram AuNP lethal effect by generating the free radicals on
the cell surface. To confirm the production of free radical, we
analyzed the AuNP by nitric oxide method. Figure 5 shows a
very encouraging trend in scavenging the NO-free radical in
a concentration dependent manner. It could be seen from this
figure that AuNP scavenged the NO-free radical five times
more effectively than BHA (butylated hydroxyanisole). At
concentrations as low as 5 μg, even where BHA had less
than 10% efficiency, bio-functionalized AgNP mopped up
more than 40% free radical in vitro. Similarly, the percentage
of quenching effect on NO-free radical was 9% with AuNP
at a minimum concentration of 2.5 μg, where BHA shows
only 3% at same concentration. AuNP and BHA scavenged
56% and 12%, respectively, at a maximum concentration of
10 μg. Statistical analysis (test of significance) of the data
obtained from the free-radical scavenging activity of AgNP
using t-test indicated that the difference on the NO-free
radical used was significant (P<0.01) than BHA.
4 Conclusion
The development of functionalized targeted gold nano-
particles as therapeutic agents has generated great interest
in both academy and industry. Targeted gold nanoparticles
have shown promising results in in vitro studies, signifying
that they are potential as therapeutic carriers. This explo-
ration creates the new avenue to a new standard where the
different flavonoids-functionalized gold nanoparticles can
be a powerful weapon against cancer.
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